Nomura Asset Management’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.58M Buy
65,370
+2,620
+4% +$184K 0.01% 607
2025
Q1
$4.63M Buy
62,750
+2,620
+4% +$194K 0.01% 590
2024
Q4
$4.17M Buy
60,130
+5,290
+10% +$367K 0.01% 615
2024
Q3
$4.61M Buy
54,840
+990
+2% +$83.2K 0.01% 599
2024
Q2
$3.65M Buy
53,850
+2,800
+5% +$190K 0.01% 616
2024
Q1
$3.21M Buy
51,050
+1,550
+3% +$97.4K 0.01% 639
2023
Q4
$2.76M Buy
49,500
+1,960
+4% +$109K 0.01% 663
2023
Q3
$2.44M Buy
47,540
+420
+0.9% +$21.6K 0.01% 663
2023
Q2
$2.47M Buy
47,120
+1,980
+4% +$104K 0.01% 677
2023
Q1
$2.33M Buy
45,140
+860
+2% +$44.4K 0.01% 668
2022
Q4
$2.31M Buy
44,280
+1,090
+3% +$56.9K 0.01% 663
2022
Q3
$2.44M Buy
43,190
+1,500
+4% +$84.8K 0.02% 622
2022
Q2
$2.53M Buy
41,690
+1,660
+4% +$101K 0.02% 646
2022
Q1
$2.36M Buy
40,030
+2,100
+6% +$124K 0.01% 695
2021
Q4
$2.18M Buy
37,930
+1,090
+3% +$62.6K 0.01% 732
2021
Q3
$1.97M Buy
36,840
+960
+3% +$51.4K 0.01% 713
2021
Q2
$2.41M Buy
35,880
+280
+0.8% +$18.8K 0.01% 693
2021
Q1
$2.57M Buy
35,600
+490
+1% +$35.4K 0.02% 640
2020
Q4
$2.43M Buy
35,110
+400
+1% +$27.7K 0.02% 641
2020
Q3
$2.09M Buy
34,710
+1,060
+3% +$63.9K 0.02% 603
2020
Q2
$2.04M Buy
33,650
+1,740
+5% +$106K 0.02% 578
2020
Q1
$1.58M Buy
31,910
+3,370
+12% +$167K 0.02% 580
2019
Q4
$2.33M Buy
28,540
+1,400
+5% +$114K 0.02% 556
2019
Q3
$2.24M Buy
27,140
+60
+0.2% +$4.94K 0.02% 542
2019
Q2
$2.11M Buy
27,080
+980
+4% +$76.5K 0.02% 560
2019
Q1
$2.05M Sell
26,100
-710
-3% -$55.8K 0.02% 564
2018
Q4
$2.03M Buy
26,810
+890
+3% +$67.2K 0.02% 501
2018
Q3
$1.96M Buy
25,920
+1,160
+5% +$87.7K 0.02% 557
2018
Q2
$1.82M Sell
24,760
-290
-1% -$21.4K 0.02% 570
2018
Q1
$1.69M Buy
25,050
+1,130
+5% +$76.1K 0.02% 575
2017
Q4
$1.8M Buy
23,920
+520
+2% +$39.2K 0.02% 546
2017
Q3
$1.81M Sell
23,400
-3,570
-13% -$276K 0.02% 509
2017
Q2
$2.14M Buy
26,970
+1,090
+4% +$86.3K 0.03% 444
2017
Q1
$1.88M Sell
25,880
-30
-0.1% -$2.18K 0.03% 489
2016
Q4
$1.92M Buy
25,910
+1,650
+7% +$122K 0.03% 438
2016
Q3
$1.9M Buy
24,260
+2,360
+11% +$185K 0.03% 438
2016
Q2
$1.64M Buy
21,900
+778
+4% +$58.4K 0.03% 465
2016
Q1
$1.41M Buy
21,122
+1,750
+9% +$116K 0.03% 511
2015
Q4
$1.18M Buy
19,372
+720
+4% +$43.8K 0.02% 549
2015
Q3
$1.07M Buy
18,652
+2,480
+15% +$143K 0.02% 566
2015
Q2
$1.01M Buy
16,172
+1,670
+12% +$104K 0.02% 601
2015
Q1
$1.03M Buy
14,502
+1,832
+14% +$130K 0.02% 599
2014
Q4
$902K Buy
12,670
+2,200
+21% +$157K 0.02% 636
2014
Q3
$598K Buy
10,470
+1,280
+14% +$73.1K 0.01% 728
2014
Q2
$575K Buy
9,190
+120
+1% +$7.51K 0.01% 743
2014
Q1
$548K Buy
9,070
+580
+7% +$35K 0.01% 751
2013
Q4
$476K Buy
8,490
+540
+7% +$30.3K 0.01% 775
2013
Q3
$452K Buy
7,950
+150
+2% +$8.53K 0.01% 768
2013
Q2
$467K Buy
+7,800
New +$467K 0.01% 754